← Leaderboards
Ben Vollrath
Vortex Therapeutics Inc
$1,102,729
Attributed
$1,102,729
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,102,729 · 1
By mechanism
R44$1,102,729 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Anti-Cancer Therapeutic”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Richard Schrock · Fisher Bioservices, Inc.$7,231,030
- Michael E. Roth · Public Health Institute$4,601,172
- Tobias Janowitz · Cold Spring Harbor Laboratory$3,678,776
- Reeder McNeil Robinson · Leukogene Therapeutics, Inc.$2,940,211
- Choi-Fong Cho · Brigham And Women'S Hospital$2,666,597
Research focus
Anti-Cancer TherapeuticBay 54-9085BeliefBreastCancer TherapyCancer TypeCanis FamiliarisCellsClinicClinical ResearchClinical TrialsC-Myc GenesComplexCoupledDimerizationDoseDrug KineticsDrug TargetingEndothelial CellsEpidermal Growth Factor ReceptorEpitheliumEventFamily MemberAndrogen Independent Prostate Cancer